Adjunctive pascolizumab in rifampicin-susceptible pulmonary tuberculosis: proof-of-concept, partially-randomised, double-blind, placebo-controlled, dose-escalation trial

Authors: Nicholas I Paton, Meera Gurumurthy, Qingshu Lu, Francesca Leek, Philip Kwan, Hiromi W L Koh, James Molton, Lalaine Mortera, Sullian Naval, Zamzurina Abu Bakar, Yong-Kek Pang, Lionel Lum, Tow Keang Lim, Gail B Cross, Ganesh Lekurwale, Hyungwon Choi, Veonice Au, John Connolly, Martin Hibberd, Justin A Green; Pascolizumab Tuberculosis Trial Team

Journal: The Journal of infectious diseases. 2024 Mar 25:jiae104.

DOI: 10.1093/infdis/jiae104

 

Notable Achievements

High Profile Publications

Short-chain fatty acids of various lengths differentially inhibit Klebsiella pneumoniae and Enterobacteriaceae species

Authors: Kai Chirng Chang, Niranjan Nagarajan, Yunn-Hwen Gan Journal: mSphere. …

High Profile Publications

Updated epithelial barrier dysfunction in chronic rhinosinusitis: Targeting pathophysiology and treatment response of tight junctions

Authors: Zhi-Qun Huang, Jing Liu, Li-Ying Sun, Hsiao Hui Ong, …

High Profile Publications

Attenuation of neurovirulence of chikungunya virus by a single amino acid mutation in viral E2 envelope protein

Authors: Huixin Chen, Patchara Phuektes, Li Sze Yeo, Yi Hao …